Friday, Oct 07, 2022

FBI arrests CEO who hiked price of HIV treatment

Martin Shkreli sparked controversy earlier this year after news reports that it had raised the price of Daraprim, a 62-year-old treatment for a dangerous parasitic infection, to $750 a tablet from $13.50 after acquiring it.

ceo, hiv, Martin Shkreli, Martin Shkreli hiv medication, hiv medication, Martin Shkreli arrest, arrest Martin Shkreli, aids, hiv news, news Activists hold signs containing the image of Turing Pharmaceuticals CEO Martin Shkreli in New York, during a protest highlighting pharmaceutical drug pricing. (Source: AP)

Martin Shkreli, a lightning rod for growing outrage over soaring prescription drug prices, was arrested by the FBI on Thursday after a federal investigation involving his former hedge fund and a pharmaceutical company he previously headed.

The securities fraud probe of Shkreli, who is now chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, stems from his time as manager of hedge fund MSMB Capital Management and CEO of biopharmaceutical company Retrophin Inc, a person familiar with the matter said.

Reuters witnessed the arrest at the Murray Hill Tower Apartments in midtown Manhattan. Law enforcement including Federal Bureau of Investigation agents could be seen escorting Shkreli, who was wearing a hoodie, into a car.

FBI spokeswoman Kelly Langmesser confirmed Shkreli’s arrest.

Subscriber Only Stories
JK Cement’s SPSU Udaipur Launches ‘Golden Batch 2022’ In Collaboration Wi...Premium
Appendicitis in Children- A new lifestyle disorderPremium
Re-Defining The Tradition In Folk Art: An Art Educator’s PerspectivePremium
Symbiosis School of Sports Sciences (SSSS) launches undergraduate program...Premium

Shares of KaloBios fell about 50 percent to $11.75 in premarket trading.

Lawyers for Retrophin and Shkreli did not immediately respond to a request for comment. Turing and KaloBios declined to comment.

Turing sparked controversy earlier this year after news reports that it had raised the price of Daraprim, a 62-year-old treatment for a dangerous parasitic infection, to $750 a tablet from $13.50 after acquiring it.

Shkreli, 32, was expected to be charged on Thursday for illegally using Retrophin assets to pay off debts after MSMB lost millions of dollars, the source said.

Advertisement

The probe, by federal prosecutors in Brooklyn, dates back to at least January when Retrophin said it received a subpoena from prosecutors seeking information about its relationship with Shkreli.

That subpoena also sought information about individuals or entities that had invested in funds previously managed by Shkreli, Retrophin said in a regulatory filing.

First published on: 17-12-2015 at 06:50:01 pm
Next Story

‘Baazigar’ sowed seeds of acting in my brain: Varun Sharma

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
X